Kestra Medical Technologies (KMTS) Amortization of Deferred Charges (2024 - 2026)
Kestra Medical Technologies (KMTS) posted quarterly Amortization of Deferred Charges of $468000.0 for Q2 2026, up 26.83% year-over-year from $369000.0 in Q2 2025, and little changed quarter-over-quarter from $469000.0 in Q1 2026.
Kestra Medical Technologies (KMTS) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Amortization of Deferred Charges for 3 consecutive years, with $468000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Amortization of Deferred Charges rose 26.83% year-over-year to $468000.0; the TTM figure through Apr 2026 stood at $1.9 million (up 33.86% YoY), while the FY2026 annual figure was $1.9 million, up 33.86% from the prior year.
- Amortization of Deferred Charges was little changed at $468000.0 in Q2 2026 per KMTS's latest filing, from $469000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $661000.0 in Q4 2024 and bottomed at $170000.0 in Q1 2025.
- Historically, Amortization of Deferred Charges has averaged $386000.0 across 3 years, with a median of $468000.0 in 2025.
- Annual changes were most pronounced in 2025 — Amortization of Deferred Charges decreased 29.2% — and 2026, when it soared 175.88%.
- Kestra Medical Technologies' Amortization of Deferred Charges stood at $661000.0 in 2024, then dropped by 29.2% to $468000.0 in 2025, then changed by 0.0% to $468000.0 in 2026.
- Business Quant data shows KMTS's Amortization of Deferred Charges at $468000.0 in Q2 2026, $469000.0 in Q1 2026, and $468000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 468,000.00 |
| Apr 30, 2026 | 468,000.00 |
| Jan 31, 2026 | 469,000.00 |
| Jan 31, 2026 | 469,000.00 |
| Oct 31, 2025 | 468,000.00 |
| Oct 31, 2025 | 468,000.00 |
| Jul 31, 2025 | 469,000.00 |
| Jul 31, 2025 | 469,000.00 |
| Apr 30, 2025 | 369,000.00 |
| Apr 30, 2025 | 369,000.00 |
| Jan 31, 2025 | 170,000.00 |
| Jan 31, 2025 | 170,000.00 |
| Oct 31, 2024 | 661,000.00 |
| Oct 31, 2024 | 661,000.00 |
| Jul 31, 2024 | 200,000.00 |
| Jul 31, 2024 | 200,000.00 |
| Apr 30, 2024 | 200,000.00 |
| Apr 30, 2024 | 200,000.00 |